<DOC>
	<DOCNO>NCT01341522</DOCNO>
	<brief_summary>Permanent cardiac pacemaker represent contraindication Magnetic Resonance Imaging ( MRI ) . Strong static , gradient radiofrequency field use MRI think detrimental pacemaker function possibly cause harm patient undergo MRI examination . A previous study show MRI indicate 17 % patient pacemaker within 12 month device placement , demonstrate need practical , safe approach perform MRI pacemaker patient . A new Reply MR-conditional pacing system develop Sorin Group safe use MRI environment . The new pacing system compose Reply pacemaker Filtrea bradycardia pace lead . This study intend demonstrate safety efficacy MRI environment Sorin Group Reply MR-conditional pacing system .</brief_summary>
	<brief_title>Clinical Evaluation Sorin Group 's REPLY MR-conditional Pacing System</brief_title>
	<detailed_description />
	<criteria>Patients candidate dualchamber pacemaker primoimplantation Patients indication implantation dualchamber pacemaker accord American College Cardiology American Heart Association Patients able willing undergo elective MRI scan Patients schedule implant Reply DR pacemaker Filtrea lead ( ) Patients provide sign date informed consent Non MRcompatible device material implant Chronic atrial fibrillation ( atrial lead evaluation ) Incessant ventricular tachyarrhythmia ( ventricular lead evaluation ) Inability understand purpose study refusal cooperate Unavailability schedule followup implant centre Already include another clinical study could affect result study Inability refusal provide informed consent Patient minor ( le 18year old ) Patient pregnant ( woman childbearing potential negative pregnancy test prior enrolment ) ; Patient life expectancy le 1 year Patient forfeiture freedom guardianship Any patient contraindication device lead labeling applies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>